Navigation Links
Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics
Date:10/8/2007

MURRYSVILLE, Pa., Oct. 8 /PRNewswire-FirstCall/ -- Dixtal Medical, Inc. and Respironics, Inc. (Nasdaq: RESP) announced today that Dixtal Medical has acquired the Novametrix pulse oximetry product line from Respironics. This pulse oximetry product line will be marketed under the Dixtal/Novametrix brand pursuant to Dixtal Medical's license of the Novametrix name from Respironics. Novametrix, founded in 1978 and acquired by Respironics in 2002, established a market-leading position in reusable pulse oximetry sensor technology and has been marketing its oximetry products for over 20 years with an emphasis on high performance, cost-effective, reusable sensors.

Dixtal Medical is a subsidiary of Dixtal Biomedica, an international medical products company based in Brazil and also established in 1978. Dixtal Biomedica is the market leader in multi-parameter monitoring products in Brazil. Dixtal Biomedica and Novametrix have conducted business together for many years, with Dixtal Biomedica manufacturing and marketing Novametrix pulse oximetry products for the Brazilian hospital market.

After Respironics' 2002 acquisition of Novametrix Medical Systems, Respironics integrated the Novametrix pulse oximetry product line into Respironics' Critical Care business. Respironics later determined that the Novametrix pulse oximetry product line was not a core technology for Respironics and made the decision to exit this line of business and refocus on its core technologies. Respironics announced its intention to exit the Novametrix pulse oximetry business in its July 2007 quarterly earnings release conference call and included the impact of this divestiture in its guidance. The sale of the Novametrix pulse oximetry business is not a material transaction for Respironics.

The sale of the Novametrix pulse oximetry business to Dixtal Medical will result in a company dedicated to the Novametrix pulse oximetry technology continuing to serve the Novametrix pulse oximetry customer base. Respironics will continue to market and sell its core multi-parameter monitoring products that contain pulse oximetry as these multi-parameter products, such as the NICO2(R), Tidal Wave(R) and CO2SMO(R) monitors, are not being sold to Dixtal Medical.

Dixtal Medical will initially focus on establishing the Dixtal/Novametrix pulse oximetry brand products with a customer-centric organization designed to support the worldwide installed base of hospitals which are utilizing Novametrix pulse oximetry products. Dixtal Medical will continue to develop the Dixtal/Novametrix pulse oximetry products and eventually will import, market, service and support Dixtal Biomedica multi-parameter monitoring systems for domestic and worldwide markets.

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and healthcare providers. Respironics markets its products in 141 countries and employs over 5,100 associates worldwide. Further information can be found on the Company's Web site: http://www.respironics.com.

FORWARD-LOOKING STATEMENT

This document contains forward-looking statements, including statements relating to, among other things, developments in the healthcare industry; the success of the Company's marketing, sales, and promotion programs; future sales, acceptance, and quality of the Company's products and programs; the results of clinical trials; the timing and success of new product introductions; new product development; anticipated cost savings; FDA and other regulatory requirements, enforcement actions, product recalls or related field actions; future results from acquisitions and strategic investments; growth rates in foreign markets; regulations and other factors affecting operations and sales outside the United States; foreign currency fluctuations; the effects of a major natural disaster, cyber-attack or other catastrophic event that results in the destruction or disruption of any critical business or information technology systems; customer consolidation and concentration; increasing price competition and other competitive factors in the manufacture, distribution, and sale of products; interest rate fluctuations; expiration of intellectual property rights; intellectual property and related litigation; other litigation; future levels of earnings and revenues; the number of equity awards granted to employees and changes in the Company's stock price; and third party reimbursement; all of which are subject to change. Actual results may differ materially from those described in any forward-looking statements. Additional information on potential factors that could affect the Company's financial results are included in the reports filed with the SEC, including the reports on Form 10-K, 10-Q and 8-K.


'/>"/>
SOURCE Respironics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology: